These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5813289)

  • 1. Stability of binding of label from N-hydroxy-N-2-fluorenylacetamide to intracellular targets, particularly deoxyribonucleic acid in rat liver.
    Szafarz D; Weisburger JH
    Cancer Res; 1969 Apr; 29(4):962-8. PubMed ID: 5813289
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite.
    Janss DH; Irving CC
    J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H; Epstein SM; Farber E
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids.
    Irving CC; Veazey RA
    Cancer Res; 1969 Oct; 29(10):1799-804. PubMed ID: 5823948
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoelectrophoretic analysis of labeling of serum proteins after administration of the carcinogen N-hydroxy-N-2-fluorenylacetamide.
    Deckers C; Grantham PH; Weisburger JH
    Cancer Res; 1968 Oct; 28(10):1990-4. PubMed ID: 4177070
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of the glucuronide of N-hydroxy-2-acetylaminofluorene in the rat.
    Irving CC; Wiseman R
    Cancer Res; 1969 Apr; 29(4):812-6. PubMed ID: 5775711
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hydrocortisone on protein synthesis in rat liver microsomes].
    Angelov EZ; Richter G
    Acta Biol Med Ger; 1969; 22(3):499-506. PubMed ID: 5363925
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
    Irving CC; Peeler TC; Veazey RA; Wiseman R
    Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
    Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
    Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between the microsomes of normal rat liver and of N-2-fluorenylacetamide-induced rat hepatoma as determined by the paired label antibody technic.
    Isojima S; Planinsek J; Yagi Y; Pressman D
    Cancer Res; 1966 Jul; 26(7):1527-33. PubMed ID: 4287849
    [No Abstract]   [Full Text] [Related]  

  • 15. Covalent binding of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene to rat liver nuclear DNA and protein in vivo and in vitro.
    Stout DL; Hemminki K; Becker FF
    Cancer Res; 1980 Oct; 40(10):3579-84. PubMed ID: 7438044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the significance and mechanism of the binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver ribonucleic acid in vivo.
    Irving CC; Veazey RA; Williard RF
    Cancer Res; 1967 Apr; 27(4):720-5. PubMed ID: 6025731
    [No Abstract]   [Full Text] [Related]  

  • 17. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
    Barry EJ; Gutmann HR
    Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
    [No Abstract]   [Full Text] [Related]  

  • 18. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
    Gutmann HR; Erickson RR
    J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymatic deacetylation of N-hydroxy-2-acetylaminofluorene by liver microsomes.
    Irving CC
    Cancer Res; 1966 Jul; 26(7):1390-6. PubMed ID: 5911580
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural modification and protein recognition of DNA modified by N-2-fluorenylacetamide, its 7-iodo derivative, and by N-2-fluorenamine.
    Daune MP; Fuchs RP; Leng M
    Natl Cancer Inst Monogr; 1981 Dec; (58):201-10. PubMed ID: 7341977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.